Nixon Peabody Trust CO Merck & Co., Inc. Transaction History
Nixon Peabody Trust CO
- $1.18 Billion
- Q4 2024
A detailed history of Nixon Peabody Trust CO transactions in Merck & Co., Inc. stock. As of the latest transaction made, Nixon Peabody Trust CO holds 84,010 shares of MRK stock, worth $6.97 Million. This represents 0.71% of its overall portfolio holdings.
Number of Shares
84,010
Previous 82,209
2.19%
Holding current value
$6.97 Million
Previous $9.34 Million
10.48%
% of portfolio
0.71%
Previous 0.79%
Shares
28 transactions
Others Institutions Holding MRK
# of Institutions
3,946Shares Held
1.93BCall Options Held
15.9MPut Options Held
14.9M-
Vanguard Group Inc Valley Forge, PA251MShares$20.8 Billion0.45% of portfolio
-
Black Rock Inc. New York, NY207MShares$17.2 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$10 Billion0.49% of portfolio
-
Wellington Management Group LLP Boston, MA80.7MShares$6.7 Billion1.51% of portfolio
-
Geode Capital Management, LLC Boston, MA61.2MShares$5.08 Billion0.48% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $210B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...